PMV Pharmaceuticals, Inc. (PMVP)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
Pre-market:
Currency in USD
Valuation measures4
| Market cap (intra-day) | 113.69M |
| Enterprise value | -71.23M |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | N/A |
| Price/book (mrq) | 0.53 |
| Enterprise value/revenue | N/A |
| Enterprise value/EBITDA | N/A |
Trading information
Stock price history
| Beta (5Y monthly) | 1.55 |
| 52-week change 3 | -61.02% |
| S&P500 52-week change 3 | 28.04% |
| 52-week high 3 | 9.7200 |
| 52-week low 3 | 1.1750 |
| 50-day moving average 3 | 1.7890 |
| 200-day moving average 3 | 3.1261 |
Share statistics
| Avg vol (3-month) 3 | 571.16k |
| Avg vol (10-day) 3 | 496.79k |
| Shares outstanding 5 | 51.44M |
| Implied shares outstanding 6 | 51.44M |
| Float 8 | 40.5M |
| % held by insiders 1 | 2.61% |
| % held by institutions 1 | 92.18% |
| Shares short (30 Apr 2024) 4 | 2.82M |
| Short ratio (30 Apr 2024) 4 | 6.22 |
| Short % of float (30 Apr 2024) 4 | 6.44% |
| Short % of shares outstanding (30 Apr 2024) 4 | 5.48% |
| Shares short (prior month 28 Mar 2024) 4 | 2.6M |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | N/A |
| Last split date 3 | N/A |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Mar 2024 |
Profitability
| Profit margin | 0.00% |
| Operating margin (ttm) | 0.00% |
Management effectiveness
| Return on assets (ttm) | -19.41% |
| Return on equity (ttm) | -29.40% |
Income statement
| Revenue (ttm) | N/A |
| Revenue per share (ttm) | N/A |
| Quarterly revenue growth (yoy) | N/A |
| Gross profit (ttm) | N/A |
| EBITDA | -74.75M |
| Net income avi to common (ttm) | -65.1M |
| Diluted EPS (ttm) | -1.3200 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 197.94M |
| Total cash per share (mrq) | 3.85 |
| Total debt (mrq) | 13.02M |
| Total debt/equity (mrq) | 6.12% |
| Current ratio (mrq) | 16.79 |
| Book value per share (mrq) | 4.13 |
Cash flow statement
| Operating cash flow (ttm) | -56.83M |
| Levered free cash flow (ttm) | -35.33M |
© 2024 Yahoo. All rights reserved.